Table of contents
June 2006 Volume 2 No 6
Top of page
Viewpoint
Top of page
Research Highlights
Further insights into the renal effects of drugs that disrupt the renin–angiotensin system
292Pediatric patients on hemodialysis experience increased arterial stiffness
292Determining the cause of fast transport status in peritoneal dialysis patients
292Novel treatment improves intradialytic hypotension
293A noninvasive proteomic method for early detection of renal allograft rejection
293Reversal of kidney damage in pancreas transplant recipients
294The antiviral properties of leflunomide in renal allograft recipients
294Genetic characterization of autosomal recessive polycystic kidney disease
295Standard assays underestimate the prevalence of albuminuria
295Reversing the progression of polycystic kidney disease with an mTOR inhibitor
295Sevelamer for treating hyperphosphatemia in pediatric CKD patients
296Modified buttonhole cannulation technique for fistulae with aneurysmal dilatation
296Downloadable models for predicting solute clearance
297Top of page
Practice Points
Doses of histamine-2-receptor antagonists should be reduced in patients with low glomerular filtration rate
298Equations used to predict glomerular filtration rate perform poorly in kidney transplant recipients
300Kidney paired donation: a single-center study of feasibility and outcomes
302Home fingerprick sampling for immunosuppressant drug monitoring in pediatric renal transplant patients
304Does pravastatin safely and effectively improve lipid profiles in children who have received a kidney transplant?
306Hypercalciuria in children with decreased muscle mass—urine calcium : osmolality versus urine calcium : creatinine
308Adding spironolactone to conventional antihypertensives reduces albuminuria in patients with diabetic nephropathy
310Do patients with type 2 diabetes on peritoneal dialysis need less insulin if they are given rosiglitazone?
312Top of page
Reviews
Reappraisal of 2003 NKF-K/DOQI guidelines for management of hyperparathyroidism in chronic kidney disease patients
326doi:10.1038/ncpneph0189 | Full Text | PDF (274K)
Guidelines for disorders of mineral metabolism and secondary hyperparathyroidism should not yet be modified
337doi:10.1038/ncpneph0190 | Full Text | PDF (118K)
Top of page
Case Study
A serum potassium level above 10 mmol/l in a patient predisposed to hypokalemia
340doi:10.1038/ncpneph0201 | Full Text | PDF (233K)
